Publication | Closed Access

Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity

NanomedicineDrug TargetingNanotherapeuticsGliomaMedicineTumor TargetingAnti-cancer AgentAnti-tumor ActivityPharmacologyRadiation OncologyTumor Biology